Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1997 participants
OBSERVATIONAL
2015-10-06
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders
NCT06037967
Immunoglobulin Gene Rearrangement and Repair in Healthy Donors
NCT04889573
Coverage and Cost-of-Care (CC) Links- Financial Navigation Program
NCT05465577
Blood Transfusion by Boston MedFlight Registry
NCT04610814
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The bio-Share study is a biological repository embedded within the i-Share study, aiming at collecting blood samples (for genetic analyses as well as measurement of other biomarkers) from a subset of 2000 i-Share participants volunteering for this ancillary project.
The goal is to set up a platform that will enable investigators in the future to study biological determinants of conditions that affect young adults and to test certain hypotheses on the pathophysiology and mechanisms underlying diseases occurring both at a young age and later in life (as early exposures may also impact late onset diseases).
The biobank will comprise the following biological materials: plasma, serum, whole blood, red blood cells, DNA, RNA. Levels of fasting glucose and lipid levels (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) will be returned to participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being aged 18 years or more
* Being affiliated or beneficiary of a social security
* Having filled out the first online i-Share questionnaire
* Having signed a written informed consent
Exclusion Criteria
* Persons who cannot personally give their consent and adults under guardianship.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Agency, France
OTHER
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie DEBETTE, MD, PhD
Role: STUDY_DIRECTOR
University of Bordeaux, Inserm U897, Bordeaux University Hospital
Christophe TZOURIO, MD, PhD
Role: STUDY_DIRECTOR
University of Bordeaux, Inserm U897, Bordeaux University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Bordeaux - PELLEGRIN
Bordeaux, Aquitaine, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX2015/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.